Study on the Correlation Factors of Tumour Prognosis after Intravascular Interventional Therapy
暂无分享,去创建一个
[1] T. de Baère,et al. Interventional Radiology for Local Immunotherapy in Oncology , 2021, Clinical Cancer Research.
[2] Mei Liu,et al. Postoperative adjuvant treatment strategy for hepatocellular carcinoma with microvascular invasion: a non-randomized interventional clinical study , 2020, BMC Cancer.
[3] Brian C. Case,et al. Intravascular lithotripsy facilitated percutaneous endovascular intervention of the aortic arch: A single-center experience. , 2020, Cardiovascular revascularization medicine : including molecular interventions.
[4] A. McCarthy,et al. Catheter‐related thrombosis incidence and risk factors in adult cancer patients with central venous access devices , 2020, Internal medicine journal.
[5] Eung Tae Kim,et al. Prevalence and predictors of peripherally inserted central venous catheter associated bloodstream infections in cancer patients , 2020, Medicine.
[6] W. Pabon-Ramos,et al. Recognition and management of dermatologic complications from interventional radiology procedures. , 2019, Diagnostic and interventional imaging.
[7] E. Soule,et al. Finally, a Minimally Invasive Option for Intrahepatic Inferior Vena Cava Invasion by Hepatocellular Carcinoma , 2018, Gastrointestinal Tumors.
[8] E. Campo,et al. Intravascular large B-cell lymphoma: a chameleon with multiple faces and many masks. , 2018, Blood.
[9] Peter Y. Kim,et al. Interventional Cardio-Oncology: Adding a New Dimension to the Cardio-Oncology Field , 2018, Front. Cardiovasc. Med..
[10] Jae C. Chang. Disseminated intravascular coagulation: is it fact or fancy? , 2018, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.
[11] J. Durand,et al. Management of CAD in Patients with Active Cancer: the Interventional Cardiologists’ Perspective , 2017, Current Cardiology Reports.
[12] M. Davies,et al. Treatment options and outcomes for caval thrombectomy and resection for renal cell carcinoma. , 2017, Journal of vascular surgery. Venous and lymphatic disorders.
[13] V. Bourcier,et al. Safety and Efficacy of Irreversible Electroporation for the Treatment of Hepatocellular Carcinoma Not Amenable to Thermal Ablation Techniques: A Retrospective Single-Center Case Series. , 2017, Radiology.
[14] Mei Qiang,et al. The efficiency analysis of thrombolytic rt-PA combined with intravascular interventional therapy in patients with acute basilar artery occlusion , 2017, International journal of biological sciences.
[15] L. Capussotti,et al. Bleeding Recurrence and Mortality Following Interventional Management of Spontaneous HCC Rupture: Results of a Multicenter European Study , 2017, World Journal of Surgery.
[16] C. Grines,et al. Vascular Toxicities of Cancer Therapies: The Old and the New – An Evolving Avenue , 2016, Circulation.
[17] S. Pascual,et al. New advances in hepatocellular carcinoma. , 2016, World journal of hepatology.
[18] M. Pai,et al. Shock, acute disseminated intravascular coagulation, and microvascular thrombosis: is ‘shock liver’ the unrecognized provocateur of ischemic limb necrosis? , 2016, Journal of thrombosis and haemostasis : JTH.
[19] B. Taslakian,et al. Patient Evaluation and Preparation in Vascular and Interventional Radiology: What Every Interventional Radiologist Should Know (Part 2: Patient Preparation and Medications) , 2016, CardioVascular and Interventional Radiology.
[20] S. Cai,et al. Diagnosis and Treatment of Abdominal Arterial Bleeding After Radical Gastrectomy: a Retrospective Analysis of 1875 Consecutive Resections for Gastric Cancer , 2015, Journal of Gastrointestinal Surgery.
[21] Lamine Mili,et al. On the Definition of Cyber-Physical Resilience in Power Systems , 2015, ArXiv.